Seres Therapeutics (MCRB) Reports Q1 Loss of $0.59

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.59), versus ($0.69) reported last year. Revenue for the quarter came in at $7.3 million, versus $3.97 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss